Investigational New Drugs,volume 27,issue 3  (06-2014)

Period of time: 2014年3期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 27,issue 3

Menu

N-benzoxazol-2-yl-N′-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential

By Hofmann Johann,Easmon Johnny,Puerstinger Gerhard,Heinisch Gottfried,Jenny Marcel,Shtil Alexander,Hermann Martin,Condorelli Daniele,Sciré Salvatore,Musumarra Giuseppe in (2009)

Investigational New Drugs,volume 27,issue 3 , Vol. 27, Iss. 3, 2009-06 , pp. 189-202

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients

By Ugidos Lisardo,Delgado Salvadora,Conill Carlos,Ginés Angels,Gallego Rosa,Ayuso Juan,Miquel Rosa,Tosca Monica,Lacy Antonio,Castells Antoni,Maurel Joan in (2009)

Investigational New Drugs,volume 27,issue 3 , Vol. 27, Iss. 3, 2009-06 , pp. 262-268

Springer Publishing Company

Abstract Access to resources Recommend Favorite